{"organizations": [], "uuid": "02dce5b8e684387574e4386bf4cd06597bf2a83f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180416.html", "section_title": "Archive News &amp; Video for Monday, 16 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/health-gilead/supreme-court-seeks-doj-view-on-gilead-whistleblower-case-idUSL1N1RU00Q", "country": "US", "domain_rank": 408, "title": "Supreme Court seeks DOJ view on Gilead whistleblower case", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.013, "site_type": "news", "published": "2018-04-17T08:34:00.000+03:00", "replies_count": 0, "uuid": "02dce5b8e684387574e4386bf4cd06597bf2a83f"}, "author": "Nate Raymond", "url": "https://www.reuters.com/article/health-gilead/supreme-court-seeks-doj-view-on-gilead-whistleblower-case-idUSL1N1RU00Q", "ord_in_thread": 0, "title": "Supreme Court seeks DOJ view on Gilead whistleblower case", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "supreme court", "sentiment": "negative"}, {"name": "gilead", "sentiment": "negative"}, {"name": "u.s. supreme court", "sentiment": "negative"}, {"name": "doj", "sentiment": "negative"}, {"name": "westlaw", "sentiment": "none"}, {"name": "gilead sciences inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "The U.S. Supreme Court on Monday asked the solicitor general to weigh in on whether to grant review in a case involving Gilead Sciences Inc to consider what constitutes a material misrepresentation by companies submitting claims to the government for payment.\nThe Supreme Courtâ€™s order came in a whistleblower lawsuit accusing Gilead of making false statements about its compliance with federal regulations in connection with HIV drugs it makes.\nTo read the full story on Westlaw Practitioner Insights, click here: bit.ly/2IWSlxa\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/", "http://bit.ly/2IWSlxa"], "published": "2018-04-17T08:34:00.000+03:00", "crawled": "2018-04-17T12:45:47.000+03:00", "highlightTitle": ""}